Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Morpholine SCHEMBL412425 | 0.95 | MEN1 (0.55) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL28817299 | 0.89 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL29071034 | 0.89 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL29377463 | 0.89 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL11120537 | 0.89 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL20580623 | 0.89 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL7727917 | 0.89 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL29208541 | 0.86 | MEN1 (0.58) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL28503414 | 0.84 | MEN1 (0.55) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL28056944 | 0.84 | MEN1 (0.55) | MEN1KMT2AKDM4EGAACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3700570-B1 | ANTISENSE OLIGOMERS FOR TREATMENT OF NON-SENSE MEDIATED RNA DECAY BASED CONDITIONS AND DISEASES | STOKE THERAPEUTICS INC (US) | 2025-01-08 | — | — | EP | claimed |
| CN-117545850-A | Method for ligating polypeptide and oligonucleotide | 南洋理工大学 | 2024-02-09 | — | — | CN | claimed |
| CN-108350005-B | Chiral agent for preparing homogeneous oligomer | 卫材R&D管理有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-114746550-A | Compositions and methods for modulating splicing and protein expression | 斯托克制药公司 | 2022-07-12 | — | — | CN | claimed |
| EP-4377461-A2 | STRUCTURE-BASED DESIGN OF ANTISENSE OLIGONUCLEOTIDE DRUGS | The Regents of University of California (US) | 2024-06-05 | — | — | EP | disclosed |
| EP-4363578-A1 | METHODS OF TREATING ALZHEIMER'S DISEASE | Aarhus Universitet (DK) | 2024-05-08 | — | — | EP | disclosed |
| CN-117858883-A | GalNAc monomer and GalNAc oligonucleotide conjugate | 莱尔纳生物制药私人有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117844807-A | Exon skipping compositions for the treatment of muscular dystrophy | 萨勒普塔医疗公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117545850-A | Method for ligating polypeptide and oligonucleotide | 南洋理工大学 | 2024-02-09 | — | — | CN | disclosed |
| CN-117136235-A | Compositions and methods for epigenetic editing | 科络玛医药公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-116947933-A | Synthesis method of 7-denitrification-2 '-deoxidization-2' -fluoro-arabinofuranose guanine phosphoramidite monomer | 南通大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-116940845-A | Method of screening for inhibitors of biomolecular interactions using phase separation as an intracellular reading | 普林斯顿大学理事会 | 2023-10-24 | — | — | CN | disclosed |
| US-20130034846-A1 | MOLECULAR BIOSENSORS CAPABLE OF SIGNAL AMPLIFICATION | MEDIOMICS LLC (US) | 2013-02-07 | — | — | US | disclosed |
| WO-2013016280-A2 | COMPOSITIONS AND METHODS FOR SELECTING APTAMERS | MEDIOMICS, LLC (US) | 2013-01-31 | — | — | WO | disclosed |
| EP-2534266-A1 | MOLECULAR BIOSENSORS CAPABLE OF SIGNAL AMPLIFICATION | Saint Louis University (US) | 2012-12-19 | — | — | EP | disclosed |
| WO-2011100561-A1 | MOLECULAR BIOSENSORS CAPABLE OF SIGNAL AMPLIFICATION | SAINT LOUIS UNIVERSITY (US) | 2011-08-18 | — | — | WO | disclosed |
| US-20110158913-A1 | Antisense and pretargeting optical imaging | UNIVERSITY OF MASSACHUSETTS (US) | 2011-06-30 | — | — | US | disclosed |
| US-20100047791-A1 | MOLECULAR ACCESSIBILITY ASSAY | NATIONAL INSTITUTES OF HEALTH | 2010-02-25 | — | — | US | disclosed |
| WO-2008091541-A1 | MOLECULAR ACCESSIBILITY ASSAY | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008088865-A2 | ANTISENSE AND PRETARGETING OPTICAL IMAGING | UNIVERSITY OF MASSACHUSETTS (US) | 2008-07-24 | — | — | WO | disclosed |